Bill > HB1455

This bill amends Section 41-149-7 of the Mississippi Code by removing references to "distributors" in provisions related to the Defending Affordable Prescription Drug Costs Act. Specifically, the bill eliminates language that previously prohibited distributors from interfering with or restricting the acquisition and delivery of 340B drugs (medications purchased at discounted rates by certain healthcare organizations under a federal program) to pharmacies contracted with 340B entities. The changes mean that only manufacturers are now explicitly restricted from denying or interfering with 340B drug transactions. The bill will take effect on July 1, 2025, and is set to be automatically repealed on June 30, 2025, creating a brief window of implementation. This legislative change appears to modify existing regulations surrounding pharmaceutical drug distribution and the 340B drug pricing program, potentially providing more flexibility for distributors in their interactions with pharmacies and 340B entities.

Health and Social Services

https://billstatus.ls.state.ms.us/2025/pdf/history/HB/HB1455.xml